CA2570383A1 - Dispositif de filtre, procede, kit et utilisation de celui-ci - Google Patents
Dispositif de filtre, procede, kit et utilisation de celui-ci Download PDFInfo
- Publication number
- CA2570383A1 CA2570383A1 CA002570383A CA2570383A CA2570383A1 CA 2570383 A1 CA2570383 A1 CA 2570383A1 CA 002570383 A CA002570383 A CA 002570383A CA 2570383 A CA2570383 A CA 2570383A CA 2570383 A1 CA2570383 A1 CA 2570383A1
- Authority
- CA
- Canada
- Prior art keywords
- filter
- filter device
- sample
- immunochemical
- binding reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 77
- 239000000463 material Substances 0.000 claims abstract description 62
- 230000009870 specific binding Effects 0.000 claims abstract description 50
- 239000012488 sample solution Substances 0.000 claims abstract description 35
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 230000000984 immunochemical effect Effects 0.000 claims abstract description 25
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 239000012491 analyte Substances 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims description 64
- 239000000243 solution Substances 0.000 claims description 38
- 239000007853 buffer solution Substances 0.000 claims description 22
- 230000027455 binding Effects 0.000 claims description 19
- 239000000427 antigen Substances 0.000 claims description 17
- 102000036639 antigens Human genes 0.000 claims description 17
- 108091007433 antigens Proteins 0.000 claims description 17
- 108010074051 C-Reactive Protein Proteins 0.000 claims description 12
- 102100032752 C-reactive protein Human genes 0.000 claims description 12
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 210000003608 fece Anatomy 0.000 claims description 8
- 208000015943 Coeliac disease Diseases 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 238000003018 immunoassay Methods 0.000 claims description 5
- 239000013641 positive control Substances 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- -1 polyethylene Polymers 0.000 claims description 4
- 208000023504 respiratory system disease Diseases 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000590002 Helicobacter pylori Species 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 229940037467 helicobacter pylori Drugs 0.000 claims description 3
- 230000014759 maintenance of location Effects 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 108700039882 Protein Glutamine gamma Glutamyltransferase 2 Proteins 0.000 claims description 2
- 102100038095 Protein-glutamine gamma-glutamyltransferase 2 Human genes 0.000 claims description 2
- 102000011923 Thyrotropin Human genes 0.000 claims description 2
- 108010061174 Thyrotropin Proteins 0.000 claims description 2
- 201000005485 Toxoplasmosis Diseases 0.000 claims description 2
- 208000026935 allergic disease Diseases 0.000 claims description 2
- 230000007815 allergy Effects 0.000 claims description 2
- 239000002981 blocking agent Substances 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 230000029142 excretion Effects 0.000 claims description 2
- 230000035558 fertility Effects 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 230000009245 menopause Effects 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 230000035935 pregnancy Effects 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 60
- 241000588724 Escherichia coli Species 0.000 description 10
- 108010062374 Myoglobin Proteins 0.000 description 8
- 102000036675 Myoglobin Human genes 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 241000193996 Streptococcus pyogenes Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000000951 immunodiffusion Effects 0.000 description 2
- 238000010329 laser etching Methods 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 208000009305 pseudorabies Diseases 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 102000004903 Troponin Human genes 0.000 description 1
- 108090001027 Troponin Proteins 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000002764 solid phase assay Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20040825A FI20040825A0 (fi) | 2004-06-15 | 2004-06-15 | Suodatinväline, sen käyttö, menetelmä ja kitti |
| FI20040825 | 2004-06-15 | ||
| US10/954,627 | 2004-09-29 | ||
| US10/954,627 US8664001B2 (en) | 2004-06-15 | 2004-09-29 | Immunochemical filter device and methods for use thereof |
| PCT/FI2005/050215 WO2005124347A1 (fr) | 2004-06-15 | 2005-06-15 | Dispositif de filtre, procédé, kit et utilisation de celui-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2570383A1 true CA2570383A1 (fr) | 2005-12-29 |
| CA2570383C CA2570383C (fr) | 2015-04-14 |
Family
ID=35509814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2570383A Expired - Fee Related CA2570383C (fr) | 2004-06-15 | 2005-06-15 | Dispositif de filtre, procede, kit et utilisation de celui-ci |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1782067A1 (fr) |
| CA (1) | CA2570383C (fr) |
| WO (1) | WO2005124347A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4672263B2 (ja) | 2004-01-27 | 2011-04-20 | デンカ生研株式会社 | 簡便な検出法、検出装置及び検出キットとその製法 |
| US7749775B2 (en) | 2006-10-03 | 2010-07-06 | Jonathan Scott Maher | Immunoassay test device and method of use |
| EP2264461A1 (fr) * | 2009-06-19 | 2010-12-22 | FZMB GmbH Forschungszentrum für Medizintechnik und Biotechnologie | Dispositif d'exécution d'un test d'échantillon chromatographique d'affinité |
| CN103969251A (zh) * | 2014-05-05 | 2014-08-06 | 湖北省食品药品监督检验研究院 | 一种集成化的化学反应快速检测装置及其方法 |
| WO2015191777A2 (fr) * | 2014-06-10 | 2015-12-17 | Dxterity Diagnostics Incorporated | Dispositifs et procédés de collecte et de stabilisation d'échantillons biologiques |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE118615T1 (de) * | 1989-04-07 | 1995-03-15 | Abbott Lab | Verfahren und vorrichtung zur trennung von plasma oder von serum aus blut. |
| US5252496A (en) * | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
| US6145688A (en) * | 1996-07-17 | 2000-11-14 | Smith; James C. | Closure device for containers |
| US6162398A (en) * | 1998-04-16 | 2000-12-19 | Becton Dickinson And Company | Assay device using shrink wrap |
| US6632681B1 (en) * | 2000-07-24 | 2003-10-14 | Ey Laboratories | Reagent delivery device and method of use |
| AU2003229455A1 (en) * | 2002-05-16 | 2003-12-02 | Medmira Inc. | Rapid vaccinia antibody detection device, method and test kit |
-
2005
- 2005-06-15 CA CA2570383A patent/CA2570383C/fr not_active Expired - Fee Related
- 2005-06-15 WO PCT/FI2005/050215 patent/WO2005124347A1/fr active Application Filing
- 2005-06-15 EP EP05754147A patent/EP1782067A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005124347A1 (fr) | 2005-12-29 |
| CA2570383C (fr) | 2015-04-14 |
| EP1782067A1 (fr) | 2007-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5416000A (en) | Analyte immunoassay in self-contained apparatus | |
| EP0319294B1 (fr) | Examen de membrane utilisant l'application concentrée d'un échantillon | |
| US6316205B1 (en) | Assay devices and methods of analyte detection | |
| JP4406510B2 (ja) | 移動を阻止するために多孔度の減少を利用したアッセイ法 | |
| EP0823972B1 (fr) | Dispositif et procede de diagnostic par detection | |
| JP3506178B2 (ja) | 対置部材クロマトグラフィー検定装置 | |
| CA2556732A1 (fr) | Dispositif d'echantillonnage et son procede d'utilisation | |
| US20030045001A1 (en) | Immunochromatographic test strip with arcuate sample application zone for ease-of-use in the field | |
| EP3665187A1 (fr) | Procédés de dosage pour la détection améliorée d'analytes | |
| CA2584076A1 (fr) | Dispositif d'analyse diagnostique | |
| WO1999022238A1 (fr) | Dispositif de dosage d'analysat | |
| JP2000321278A (ja) | 改善された免疫クロマトグラフィー分析 | |
| WO2007047924A2 (fr) | Détection d'un ligand cible améliorée | |
| US9207248B2 (en) | Diagnostic detection devices and methods | |
| US8664001B2 (en) | Immunochemical filter device and methods for use thereof | |
| JP3640278B2 (ja) | アッセイ装置およびそれを用いるアッセイ方法 | |
| EP0888547B1 (fr) | Analyse immunologique du sang entier | |
| US20020036170A1 (en) | Lateral flower plasma separation device | |
| CA2570383C (fr) | Dispositif de filtre, procede, kit et utilisation de celui-ci | |
| JP3859027B2 (ja) | 乳頭分泌液中の特定物質の測定方法 | |
| JPS63210664A (ja) | 酸素要求検出系を用いる装置のための乾燥試験片及び被検流体中の分析成分の検出方法 | |
| US20240077478A1 (en) | System for rapid analysis of a capillary blood sample from a subject, intended for detecting the presence of at least one analyte in said capillary blood sample | |
| JPH0933526A (ja) | 免疫学的検査キット | |
| MXPA97008428A (es) | Dispositivo y metodo para la deteccion de diagnostico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20180615 |